Berciano-Guerrero, M.-A.; Lavado-Valenzuela, R.; Moya, A.; delaCruz-Merino, L.; Toscano, F.; Valdivia, J.; Castellón, V.; Henao-Carrasco, F.; Sancho, P.; Onieva-Zafra, J.-L.;
et al. Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy. Biomedicines 2022, 10, 284.
https://doi.org/10.3390/biomedicines10020284
AMA Style
Berciano-Guerrero M-A, Lavado-Valenzuela R, Moya A, delaCruz-Merino L, Toscano F, Valdivia J, Castellón V, Henao-Carrasco F, Sancho P, Onieva-Zafra J-L,
et al. Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy. Biomedicines. 2022; 10(2):284.
https://doi.org/10.3390/biomedicines10020284
Chicago/Turabian Style
Berciano-Guerrero, Miguel-Angel, RocÃo Lavado-Valenzuela, Aurelio Moya, Luis delaCruz-Merino, Fátima Toscano, Javier Valdivia, Victoria Castellón, Fernando Henao-Carrasco, Pilar Sancho, Juan-Luis Onieva-Zafra,
and et al. 2022. "Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy" Biomedicines 10, no. 2: 284.
https://doi.org/10.3390/biomedicines10020284
APA Style
Berciano-Guerrero, M.-A., Lavado-Valenzuela, R., Moya, A., delaCruz-Merino, L., Toscano, F., Valdivia, J., Castellón, V., Henao-Carrasco, F., Sancho, P., Onieva-Zafra, J.-L., Navas-Delgado, I., Rueda-Dominguez, A., Perez-Ruiz, E., & Alba, E.
(2022). Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy. Biomedicines, 10(2), 284.
https://doi.org/10.3390/biomedicines10020284
